Across TCGA pan-cancer cohorts, FOXN3P2 RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of FOXN3P2’s most consistent transcriptional readouts.

The strongest signal is observed in breast invasive carcinoma (BRCA), where FOXN3P2 RNA is repressed in tumor relative to normal tissue. In most cancer types FOXN3P2 is over-expressed in tumor, although a few such as BRCA and HNSC show the opposite, repressed pattern.

BRCA and HNSC are the cancer types where FOXN3P2 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in FOXN3P2 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
BRCA	All	II,III,IV	−0.064	.037	2	view →
HNSC	Male	All	−0.056	.025	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 2 strongest of 2 lineages.

Exploration

Same gene, other analysis: FOXN3P2 RNA expression & survival · all FOXN3P2 data types